Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Chris Wallick, Ning Wu, Tu My To, Daniel Keebler & Dalia Moawad. (2021) Antiviral use is associated with a decrease in the rate of influenza-related complications, health care resource utilization, and costs. Journal of Medical Economics 24:1, pages 386-393.
Read now
Read now
Vanessa Taieb, Hidetoshi Ikeoka, Fang-Fang Ma, Katarzyna Borkowska, Samuel Aballéa, Keiko Tone & Nobuo Hirotsu. (2019) A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients. Current Medical Research and Opinion 35:8, pages 1355-1364.
Read now
Read now
Anita J. Brogan, Sandra E. Talbird, Ashley E. Davis, Edward W. Thommes & Genevieve Meier. (2017) Cost-effectiveness of seasonal quadrivalent versus trivalent influenza vaccination in the United States: A dynamic transmission modeling approach. Human Vaccines & Immunotherapeutics 13:3, pages 533-542.
Read now
Read now
Philip J. Spagnuolo, Mengxi Zhang, Yaping Xu, Jian Han, Shuqian Liu, Jinan Liu, Maureen Lichtveld & Lizheng Shi. (2016) Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006–2010. Current Medical Research and Opinion 32:8, pages 1399-1407.
Read now
Read now
Michael G Ison. (2015) Optimizing antiviral therapy for influenza: understanding the evidence. Expert Review of Anti-infective Therapy 13:4, pages 417-425.
Read now
Read now
Paolo Preziosi. (2011) Influenza pharmacotherapy: present situation, strategies and hopes. Expert Opinion on Pharmacotherapy 12:10, pages 1523-1549.
Read now
Read now
Articles from other publishers (28)
Robyn Harrison, Samira Mubareka, Jesse Papenburg, Tilman Schober, Upton D Allen, Todd F Hatchette & Gerald A Evans. (2023) AMMI Canada 2023 update on influenza: Management and emerging issues. Journal of the Association of Medical Microbiology and Infectious Disease Canada, pages 176-186.
Crossref
Crossref
Edward E. Neuberger, Tu My To, Arpamas Seetasith, Stella M. Arndorfer & Chris J. Wallick. (2022)
Antiviral Use and Health Care Use Among
US
Patients With Rheumatoid Arthritis and Influenza in Three Influenza Seasons, 2016‐2019
. ACR Open Rheumatology 4:7, pages 631-639.
Crossref
Crossref
Xiao Li, Joke Bilcke, Alike W. van der Velden, Emily Bongard, Robin Bruyndonckx, Pär-Daniel Sundvall, Nicolay J. Harbin, Samuel Coenen, Nick Francis, Pascale Bruno, Ana Garcia-Sangenis, Dominik Glinz, Katarzyna Kosiek, Réka Mikó-Pauer, Ruta Radzeviciene Jurgute, Bohumil Seifert, Nikolaos Tsakountakis, Rune Aabenhus, Christopher C. Butler & Philippe Beutels. (2021) Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial. Clinical Drug Investigation 41:8, pages 685-699.
Crossref
Crossref
Vanessa Taieb, Hidetoshi Ikeoka, Fang-Fang Ma, Katarzyna Borkowska, Samuel Aballea, Keiko Tone & Nobuo Hirotsu. (2020) A network meta-analysis of the efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors for the treatment of influenza in otherwise healthy patients. Terapevticheskii arkhiv 92:11, pages 122-131.
Crossref
Crossref
Kyeong Hyang Byeon, Jaiyong Kim, Bo Youl Choi, Jin Yong Kim & Nakyoung Lee. (2020) Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014–2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season. Journal of Korean Medical Science 35:38.
Crossref
Crossref
Sudhir Venkatesan, Puja R Myles, Kirsty J Bolton, Stella G Muthuri, Tarig Al Khuwaitir, Ashish P Anovadiya, Eduardo Azziz-Baumgartner, Tahar Bajjou, Matteo Bassetti, Bojana Beovic, Barbara Bertisch, Isabelle Bonmarin, Robert Booy, Victor H Borja-Aburto, Heinz Burgmann, Bin Cao, Jordi Carratala, Tserendorj Chinbayar, Catia Cilloniz, Justin T Denholm, Samuel R Dominguez, Pericles A D Duarte, Gal Dubnov-Raz, Sergio Fanella, Zhancheng Gao, Patrick Gérardin, Maddalena Giannella, Sophie Gubbels, Jethro Herberg, Anjarath Lorena Higuera Iglesias, Peter H Hoeger, Xiao Yun Hu, Quazi T Islam, Mirela F Jiménez, Gerben Keijzers, Hossein Khalili, Gabriela Kusznierz, Ilija Kuzman, Eduard Langenegger, Kamran B Lankarani, Yee-Sin Leo, Romina P Libster, Rita Linko, Faris Madanat, Efstratios Maltezos, Abdullah Mamun, Toshie Manabe, Gokhan Metan, Auksė Mickiene, Dragan Mikić, Kristin G I Mohn, Maria E Oliva, Mehpare Ozkan, Dhruv Parekh, Mical Paul, Barbara A Rath, Samir Refaey, Alejandro H Rodríguez, Bunyamin Sertogullarindan, Joanna Skręt-Magierło, Ayper Somer, Ewa Talarek, Julian W Tang, Kelvin To, Dat Tran, Timothy M Uyeki, Wendy Vaudry, Tjasa Vidmar, Paul Zarogoulidis, Nisreen Amayiri, Robed Amin, Clarissa Baez, Carlos Bantar, Jing Bao, Mazen Mahmoud Barhoush, Ariful Basher, Julie Bettinger, Emilio Bouza, Ilkay Bozkurt, Elvira Čeljuska-Tošev, Kenny K C Chan, Yusheng Chen, Rebecca Cox, Maria R Cuezzo, Wei Cui, Simin Dashti-Khavidaki, Bin Du, Hicham El Rhaffouli, Hernan Escobar, Agnieszka Florek-Michalska, John Gerrard, Stuart Gormley, Sandra Götberg, Matthias Hoffmann, Behnam Honarvar, Edgar Bautista, Amr Kandeel, Jianmin Hu, Christoph Kemen, Gulam Khandaker, Marian Knight, Evelyn S C Koay, Miroslav Kojic, Koichiro Kudo, Arthur Kwan, Idriss Lahlou Amine, Win Mar Kyaw, Leonard Leibovici, Hongru Li, Xiao-Li Li, Pei Liu, Tze Ping Loh, Deborough Macbeth, Magdalena Marczyńska, Fabiane Pinto Mastalir, Allison McGeer, Mohsen Moghadami, Lilian Moriconi, Pagbajabyn Nymadawa, Bulent Ozbay, Fernando P Polack, Philippe Guillaume Poliquin, Wolfgang Pöppl, Alberto Rascon Pacheco, Blaž Pečavar, Mahmudur Rahman, Elena B Sarrouf, Brunhilde Schweiger, Fang Gao Smith, Antoni Torres, Selda Hancerli Torun, C B Tripathi, Daiva Velyvyte, Diego F Viasus, Qin Yu, Kwok-Yung Yuen, Wei Zhang, Wei Zuo & Jonathan S Nguyen-Van-Tam. (2019) Neuraminidase Inhibitors and Hospital Length of Stay: A Meta-analysis of Individual Participant Data to Determine Treatment Effectiveness Among Patients Hospitalized With Nonfatal 2009 Pandemic Influenza A(H1N1) Virus Infection. The Journal of Infectious Diseases.
Crossref
Crossref
Fred Y Aoki, Upton D Allen, Samira Mubareka, Jesse Papenburg, H Grant Stiver & Gerald A Evans. (2019) Use of antiviral drugs for seasonal influenza: Foundation document for practitioners—Update 2019. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 4:2, pages 60-82.
Crossref
Crossref
Laure-Anne Van Bellinghen, Alen Marijam, Gabriela Tannus Branco de Araujo, Jorge Gomez & Ilse Van Vlaenderen. (2018) Cost-utility of quadrivalent versus trivalent influenza vaccine in Brazil – comparison of outcomes from different static model types. The Brazilian Journal of Infectious Diseases 22:1, pages 1-10.
Crossref
Crossref
Sudhir Venkatesan, Puja R. Myles, Jo Leonardi-Bee, Stella G. Muthuri, Malak Al Masri, Nick Andrews, Carlos Bantar, Gal Dubnov-Raz, Patrick Gérardin, Evelyn S. C. Koay, Tze Ping Loh, Ziad Memish, Elizabeth Miller, Maria E. Oliva, Barbara A. Rath, Brunhilde Schweiger, Julian W. Tang, Dat Tran, Tjasa Vidmar, Pauline A. Waight & Jonathan S. Nguyen-Van-Tam. (2017) Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis. Clinical Infectious Diseases 64:10, pages 1328-1334.
Crossref
Crossref
Léon Nshimyumukiza, Xavier Douville, Diane Fournier, Julie Duplantie, Rana K. Daher, Isabelle Charlebois, Jean Longtin, Jesse Papenburg, Maryse Guay, Maurice Boissinot, Michel G. Bergeron, Denis Boudreau, Christian Gagné, François Rousseau & Daniel Reinharz. (2016) Cost‐effectiveness analysis of antiviral treatment in the management of seasonal influenza A: point‐of‐care rapid test versus clinical judgment. Influenza and Other Respiratory Viruses 10:2, pages 113-121.
Crossref
Crossref
Ralph Crott, Isabelle Pouplier, Isabelle Roch, Yi-Chen Chen & Marie-Christine Closon. (2014) Pneumonia and influenza, and respiratory and circulatory hospital admissions in Belgium: a retrospective database study. Archives of Public Health 72:1.
Crossref
Crossref
M. G. Ison. (2014) Editorial Commentary: Failing Our Patients by Suboptimally Treating Influenza Infections. Clinical Infectious Diseases 59:6, pages 783-786.
Crossref
Crossref
Jacqueline K. Lim, Tae Hee KimPaul E. KilgoreAllison E. AielloByung Min Choi, Kwang Chul Lee, Kee Hwan Yoo, Young-Hwan Song & Yun-Kyung Kim. (2014) The Association between Influenza Treatment and Hospitalization-Associated Outcomes among Korean Children with Laboratory-Confirmed Influenza. Journal of Korean Medical Science 29:4, pages 485.
Crossref
Crossref
Upton D Allen. (2013) L’utilisation d’antiviraux contre l’influenza : des conseils pour les praticiens en 2012-2013 – Sommaire relatif à la pédiatrie. Paediatrics & Child Health 18:3, pages 159-162.
Crossref
Crossref
Charles R. Beck, Rachel Sokal, Nachiappan Arunachalam, Richard Puleston, Anna Cichowska, Anthony Kessel, Maria Zambon & Jonathan S. Nguyen‐Van‐Tam. (2012) Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic. Influenza and Other Respiratory Viruses 7:s1, pages 14-24.
Crossref
Crossref
Kay Wang, Matthew Shun‐Shin, Peter Gill, Rafael Perera & Anthony Harnden. (2012) Cochrane Review: Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Evidence-Based Child Health: A Cochrane Review Journal 7:5, pages 1719-1790.
Crossref
Crossref
Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera & Anthony Harnden. (2012) Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database of Systematic Reviews.
Crossref
Crossref
Shikha Garg, Alicia M. Fry, Monica Patton, Anthony E. Fiore & Lyn Finelli. (2012) Antiviral Treatment of Influenza in Children. Pediatric Infectious Disease Journal 31:2, pages e43-e51.
Crossref
Crossref
Kay Wang, Matthew Shun-Shin, Peter Gill, Rafael Perera & Anthony Harnden. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
&NA;. (2011) Consider the early use of antivirals when battling influenza infection in children. Drugs & Therapy Perspectives 27:10, pages 11-14.
Crossref
Crossref
Jonathan A McCullers. (2011) Preventing and Treating Secondary Bacterial Infections with Antiviral Agents. Antiviral Therapy 16:2, pages 123-135.
Crossref
Crossref
Elena A. Govorkova & Jonathan A. McCullers. 2013. Swine Influenza. Swine Influenza
273
300
.
Steven M. Smith & John G. Gums. (2010) Antivirals for Influenza. Pediatric Drugs 12:5, pages 285-299.
Crossref
Crossref
R. Dutkowski. (2010) Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. Journal of Antimicrobial Chemotherapy 65:Supplement 2, pages ii11-ii24.
Crossref
Crossref
Aimee K. Zaas, Minhua Chen, Jay Varkey, Timothy Veldman, Alfred O. HeroIIIIII, Joseph Lucas, Yongsheng Huang, Ronald Turner, Anthony Gilbert, Robert Lambkin-Williams, N. Christine Øien, Bradly Nicholson, Stephen Kingsmore, Lawrence Carin, Christopher W. Woods & Geoffrey S. Ginsburg. (2009) Gene Expression Signatures Diagnose Influenza and Other Symptomatic Respiratory Viral Infections in Humans. Cell Host & Microbe 6:3, pages 207-217.
Crossref
Crossref
Ashley Roberts & Joanne M. Langley. 2009. Evidence‐Based Infectious Diseases. Evidence‐Based Infectious Diseases
206
212
.
Jeffrey A. Linder, Harry Reyes Nieva & William A. Blumentals. (2009) Antiviral and Antibiotic Prescribing for Influenza in Primary Care. Journal of General Internal Medicine 24:4, pages 504-510.
Crossref
Crossref
Sandra E. Talbird, Anita J. Brogan, Aleksander P. Winiarski & Beate Sander. (2009) Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. American Journal of Health-System Pharmacy 66:5, pages 469-480.
Crossref
Crossref